Page last updated: 2024-08-18

4-butyrolactone and Adenocarcinoma of Lung

4-butyrolactone has been researched along with Adenocarcinoma of Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
An, H; Bai, X; Guo, S; Kang, X; Li, S; Liu, X; Shi, S1
Blancafort, A; CufĂ­, S; Haro, D; Marrero, PF; Oliveras, G; Puig, T; Relat, J1

Other Studies

2 other study(ies) available for 4-butyrolactone and Adenocarcinoma of Lung

ArticleYear
Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 153

    Topics: 4-Butyrolactone; Adenocarcinoma of Lung; Apoptosis; Cell Line, Tumor; Doxorubicin; Glucosides; Humans; Lung Neoplasms; Molecular Docking Simulation

2022
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.
    BMC cancer, 2012, Jul-06, Volume: 12

    Topics: 4-Butyrolactone; Adenocarcinoma; Adenocarcinoma of Lung; Analysis of Variance; Animals; Apoptosis; Carnitine O-Palmitoyltransferase; Catechin; Cell Line, Tumor; Fatty Acid Synthases; Fatty Acids; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Random Allocation; Signal Transduction; Weight Loss; Xenograft Model Antitumor Assays

2012